⌘K

Home/Filings/4/0001398344-25-007141

4//SEC Filing

POPLAR POINT CAPITAL MANAGEMENT LLC 4

Accession 0001398344-25-007141

CIK 0001389545other

View on SEC.gov Company Profile

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 12:30 PM ET

Size

17.8 KB

Accession

0001398344-25-007141

Insider Transaction Report

Form 4

Period: 2025-03-10

NovaBay Pharmaceuticals, Inc.NBY

POPLAR POINT CAPITAL MANAGEMENT LLC

10% Owner

Transactions

Purchase
Common Stock, par value $0.01 per share
2025-03-14$0.63/sh+25,511$16,072→ 808,277 total
Purchase
Common Stock, par value $0.01 per share
2025-03-18$0.63/sh+10,000$6,300→ 818,277 total
Purchase
Common Stock, par value $0.01 per share
2025-03-13$0.64/sh+34$22→ 782,766 total
Purchase
Common Stock, par value $0.01 per share
2025-03-11$0.58/sh+2,148$1,246→ 770,895 total
Purchase
Common Stock, par value $0.01 per share
2025-03-10$0.58/sh+14,645$8,494→ 768,747 total
Purchase
Common Stock, par value $0.01 per share
2025-03-12$0.62/sh+11,837$7,370→ 782,732 total

POPLAR POINT CAPITAL GP LLC

10% Owner

Transactions

Purchase
Common Stock, par value $0.01 per share
2025-03-18$0.63/sh+10,000$6,300→ 818,277 total
Purchase
Common Stock, par value $0.01 per share
2025-03-13$0.64/sh+34$22→ 782,766 total
Purchase
Common Stock, par value $0.01 per share
2025-03-14$0.63/sh+25,511$16,072→ 808,277 total
Purchase
Common Stock, par value $0.01 per share
2025-03-11$0.58/sh+2,148$1,246→ 770,895 total
Purchase
Common Stock, par value $0.01 per share
2025-03-10$0.58/sh+14,645$8,494→ 768,747 total
Purchase
Common Stock, par value $0.01 per share
2025-03-12$0.62/sh+11,837$7,370→ 782,732 total

10% Owner

Transactions

Purchase
Common Stock, par value $0.01 per share
2025-03-13$0.64/sh+34$22→ 782,766 total
Purchase
Common Stock, par value $0.01 per share
2025-03-14$0.63/sh+25,511$16,072→ 808,277 total
Purchase
Common Stock, par value $0.01 per share
2025-03-18$0.63/sh+10,000$6,300→ 818,277 total
Purchase
Common Stock, par value $0.01 per share
2025-03-10$0.58/sh+14,645$8,494→ 768,747 total
Purchase
Common Stock, par value $0.01 per share
2025-03-11$0.58/sh+2,148$1,246→ 770,895 total
Purchase
Common Stock, par value $0.01 per share
2025-03-12$0.62/sh+11,837$7,370→ 782,732 total

POPLAR POINT CAPITAL PARTNERS LP

10% Owner

Transactions

Purchase
Common Stock, par value $0.01 per share
2025-03-12$0.62/sh+11,837$7,370→ 782,732 total
Purchase
Common Stock, par value $0.01 per share
2025-03-18$0.63/sh+10,000$6,300→ 818,277 total
Purchase
Common Stock, par value $0.01 per share
2025-03-11$0.58/sh+2,148$1,246→ 770,895 total
Purchase
Common Stock, par value $0.01 per share
2025-03-14$0.63/sh+25,511$16,072→ 808,277 total
Purchase
Common Stock, par value $0.01 per share
2025-03-10$0.58/sh+14,645$8,494→ 768,747 total
Purchase
Common Stock, par value $0.01 per share
2025-03-13$0.64/sh+34$22→ 782,766 total

Footnotes (1)

[F1]This Form 4 is being jointly filed by Poplar Point Capital Partners LP ("PPCP"), Poplar Point Capital Management LLC ("PPCM"), Poplar Point Capital GP LLC ("PPCGP"), and Mr. Jad Fakhry (collectively with PPCP, PPCM and PPCGP, the "Reporting Persons") with respect to shares of common stock of the above named issuer owned by PPCP. PPCM is the investment manager of PPCP. PPCGP is the general partner of PPCP. Mr. Fakhry is the manager of PPCM and PPCGP, and owns a controlling interest in, PPCM and PPCGP. The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any).

Documents

1 file

4
fp0093058-4_4.xmlPrimary

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001588273

Filing Metadata

Form type: 4
Filed: Apr 14, 8:00 PM ET
Accepted: Apr 15, 12:30 PM ET
Size: 17.8 KB

View on SEC.gov